Nadda opens facility for manufacture of vaccines in Kasauli

  • News
  • April 30, 2016

Shimla
Union health minister JP Nadda inaugurated the Current Good Manufacturing Practise (CGMP) compliant facility for manufacture of DPT and TT vaccine at the Central Research Institute (CRI), Kasauli. This makes CRI, which will celebrate its 111th foundation day in May, the first Central government institute to have CGMP compliant infrastructure for production of vaccines. The minister also said CRI is exploring the feasibility of establishing a WHO pre-qualified CGMP compliant manufacturing facility for the yellow fever vaccine. This will enable the institute to supply the vaccine to African and Latin American countries, he said. Nadda announced the zonal office of the Central Drugs Standard Control Organization (CDSCO) will function from the Container Corporation of India building, Baddi to help pharma companies and exporters from Himachal Pradesh, Punjab and Haryana get clearances and no objection certificates. The CDSCO office will start working within a week, he said, adding that the HP government has agreed to provide land for the zonal office of CDSCO in Baddi. Three to four workshops on good manufacturing and laboratory practices will be organized at Baddi in May to ensure production of quality medicines. TT vaccine has been commercialized from this facility for use in the Universal Immunization Programme and production of DPT bulk has also been initiated. CRI is in process of acquiring 128 bighas of land from Himachal Pradesh government for the creation of the CGMP compliant facility for manufacturing of therapeutic anti-sera. The initiative will increase production capacity of the institute to cater to the spiralling demand for the lifesaving anti-sera and generate significant amount of employment opportunities for youth in the country.

Related Posts

MedTech Zone AMTZ Puts Vizag on the Science Map of India

Vizag Science &Technology Cluster rated as one of the India’s Strategic Innovation Hubs Visakhapatnam, June 28 – In a significant boost to Vizag’s growing scientific stature, the Andhra Pradesh MedTech…

  • News
  • May 27, 2025
  • 246 views
Ramping Up Community for JeevanRaksha during Disasters

CBDM India 2025 will Champion Health Resilience and Local Response Bengaluru: As India and its neighbours continue to confront the double threat of increasing natural disasters and unpredictable man-made crises—including…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

MedTech Zone AMTZ Puts Vizag on the Science Map of India

MedTech Zone AMTZ Puts Vizag on the Science Map of India

Bharat Biotech, GSK to cut malaria vaccine price by more than half by 2028

Bharat Biotech, GSK to cut malaria vaccine price by more than half by 2028

Sun Pharma ropes in Richard Ascroft as North America CEO

Sun Pharma ropes in Richard Ascroft as North America CEO

Torrent Pharma shares surge 4% as JPMorgan upgrades to overweight; 18% upside seen

Torrent Pharma shares surge 4% as JPMorgan upgrades to overweight; 18% upside seen